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Background: Dai Huang Fu Zi Tang (DHFZT), an oriental herbal formula, has long been used clinically in treatment
of intestinal obstruction, acute pancreatitis, cholecystalgia and chronic diarrhea for thousands of years. Recent
studies have demonstrated that DHFZT can reduce intestinal pathological injury and the concentration of
enterogenous endotoxin in an animal model. But the underlying mechanism has not been fully elucidated.
Methods: SD male rats in adult were used to model HS and treated with DHFZT. The serum concentration of endotoxin
were analyzed by dynamic turbidimetric method. In addition, the blood flow of small intestine were measured using laser
speckle technique. Phosphorylated vasodilator-stimulated phosphoprotein (p-VASP) and zonula occludens (ZO)-1 protein,
intestinal fatty acid binding protein (IFABP) were measured by Western Blotting, RT-PCR, ELISA respectively.
Results: Present study showed that DHFZT markedly elevated the blood flow of small intestine, protected the intestinal
barrier function by up-regulating the expression of ZO-1 protein and down-regulating expression of p-VASP, and notely
decreased serum concentration of IFABP and endotoxin in HS.
Conclusions: These results reveal that DHFZT improves intestinal blood flow, protects the intestinal barrier function, and
ameliorates intestinal endotoxaemia in rats with HS.
Keywords: Hemorrhagic shock, Dai Huang Fu Zi Tang, Endotoxin, Small intestine, Phosphorylated vasodilator-stimulated
phosphoprotein (p-VASP), Zonula occludens (ZO)-1 protein, Intestinal fatty acid binding protein (IFABP)Background
Hemorrhagic shock (HS) accounts for 30% of deaths from
injury around the world in 2008. Its mortality range 36.5%
from 69% [1,2]. HS is a clinical syndrome resulting from
circulatory dysfunction that leads to decreased tissue
ischemia, the accumulation of oxygen debt, and ultimately
to multiple organ injury and death if left untreated [3].
Many previous studies have shown that after HS, intestinal
ischemia continuously and Gut-derived endotoxemia are* Correspondence: dllxg@126.com; zlbdl_04@vip.163.com
†Equal contributors
1Department of Emergency Medicine, Zhongshan Hospital, Dalian University,
Dalian 116001, China
3Department of Traditional Chinese Medicine, the Second Affiliated Hospital,
Dalian Medical University, Dalian 116023, China
Full list of author information is available at the end of the article
© 2014 Lu et al.; licensee BioMed Central Ltd.
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.very important driving factor of HS into multiple organ
dysfunction syndrome (MODS) [4-6]. So, how to increase
the intestinal blood flow, protect intestinal normal function
and reduce the serum endotoxin level are the key steps of
improving the prognosis and reducing mortality.
Dai Huang Fu Zi Tang(DHFZT), a prescription in trad-
itional Chinese medicine (TCM), has been used to cure
Acute appendicitis, acute intestinal obstruction, acute pan-
creatitis, shock, etc [7-10]. DHFZT composed of three
herbs including Radix et Rhizoma Rhei (DH), Radix
Aconiti Lateralis Praeparata (FZ) and Radix et Rhizoma
Asari (XX), was originally described in the Synopsis of
Golden Chamber (Jin Kui Yao Lue), a treatise on fe-
brile and miscellaneous diseases written by the outstand-
ing physician Zhang Zhongjing in Han Dynasty.This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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DHFZT had reduced serum concentration of endotoxin
and protected the intestinal barrier function of rats [11].
However,the underlying mechanisms of these protective
effects remain unclear. In this study, we applied a HS
model to discuss mechamism of DHFZT in rats.
Methods
Material
Rat intestinal fatty acid binding protein (IFABP) ELISA
kit was purchased from Cusabio Co., Ltd (Wuhai, China).
EKT-5 M set dynamic Gram-negative bacteria test
kit was obtained from Gold Mountainriver Techn
Development Co. Ltd (Beijing, China). Rabbit anti-rat
phosphorylated vasodilator-stimulated phosphoprotein
(p-VASP) antibody was purchased from Cell Signaling
Technology, Inc (Boston, United States). Rabbit anti-rat
zonula occluden (ZO-1) antibody was obtained from
Santa Cruz Biotechnology, Inc (California, United States).
SP9001 anti-rabbit immunohistochemical detection kit and
DAB reagent kit were purchased from Beijing Zhongshan
Golden Bridge Biotechnology Co., Ltd (Beijing, China).
Preparation and quality controls of DHFZT
DHFZT is composed of 3 species of herbal plants,
each dried crude drug of which were purchased from Tong
Ren Tang Group Co., Ltd (Beijing, China). The for-
mula of DHFZT is described in Table 1, and voucher
specimen of Rheum palmatum Linn (No.00000022),
Aconitum carmichaeli Debeaux (No.01814237), and
Asarum heterotropoides F.S chmidt var.mandshuricum
(No.00916696) are kept in Institute of Botany, the
Chinese Academy of Sciences. The herbal components
were identified by one of the authors [12]. To keep
the consistency of the herbal chemical ingredients, all
of the herbal components were originally obtained from
the standard native sources as stated above with GAP
grade and the drugs were extracted with standard
methods according to Chinese Pharmacopeoia III (edition
2010). Standard substance, such as Rheum emodin, rhein,
rhubarb phenol, aconitine and physcion, with purity of
99% or higher were purchased from the National Institute
for the Control of Pharmaceutical and Biological ProductsTable 1 Herbal compositions of DHFZT
Scientific name Herbal name Quantity
(dry, g)
Rheum palmatum Linn Radix et Rhizoma Rhei (DH) 9.0




F. Schmidt var. mandshuricum
Radix et Rhizoma Asari (XX) 3.0
Total 21.0(Beijing, China). Methyl eugenol and Asarum ether were
purchased from Sigma, St (Louis, Mo, United States).
Its chemical ingredients were confirmed at Chemical
Analysis Center of Technology Institute, Dalian University
of Technology.
According to the original prescription from the 〝Jin
Kui Yao Lue〞, DH, FZ and XX were mixed in the ration
of 3:3:1 (w/w). First, FZ were soaked in water (1:25) for
30 min, followed by extraction in boiling water (100°C) for
1 h. Then DH was added and boiled for 10 min. Finally,
XX was added and boiled for 5 min. The DHFZT were
concentrated by rotary evaporator (Heidolph Instruments,
Germany) and lyophilized to obtain dry extract through
freeze-drying system (Labconco, United States) at −80°C,
yielding final 3.72 g (extraction ratio 17.71%), and stored
at 4°C for use. The lyophilized DHFZT extract was
dissolved in an appropriate volume of 0.9% normal saline
prior to administrating to rats.
Animals
A total of 72 Sprague–Dawley male rats (age, 5–7 weeks;
weight, 250–300 g) were purchased from the Dalian
Medical University Experimental Animal Center. Animals
were housed in a colony room under a 12:12 light–dark
cycle (lights on from 7:30 a.m. to 7:30 p.m.) at constant
temperature (23 ± 1°C) and humidity (50 ± 5%). All proce-
dures involving animals were conducted in conformity with
the National Institute of Health Guide for the Care and Use
of Laboratory Animals and were approved by the Dalian
University Animal Research Ethics Committee. Anesthetic
drugs and all other necessary measures were used to reduce
animal suffering during experimental procedures.
Experiments design
The experiment aimed to test whether DHFZT could
increase intestinal blood flow, and protect barrier
function of intestine, and then decrease intestinal
endotoxaemia in rats with HS. Rats were anesthetized
with ether inhalation for narcotic induction and then
by injecting 2% of sodium pentobarbital (40 mg/kg)
into the abdominal cavity for maintaining anesthesia.
Morphine hydrochloride (5 ~ 10 mg/kg) by subcutaneous
injection was used to ease pain 20 min before anesthesia.
With aseptic technique, poly-ethylene (PE50) catheters
were placed in the right carotid artery for continuous
mean arterial pressure (MAP) monitoring with a
multifunctional physiological recorder (BIOPAC, USA)
in the left femoral artery for blood withdrawal and in
the right femoral vein for fluid infusion. A rat model
with controlled HS model was induced following a
simple modification of the method described previ-
ously [13,14]. The MAP was gradually reduced to
40 mmHg by withdrawing blood within 10 min in a
syringe prerinsed with 0.02 ml heparin (1,000 IU/ml),
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40 mmHg for 60 min before fluid resuscitation was
initiated. HS model of rat was thus successfully developed,
followed by resuscitation with all the blood released and 2
times amount of normal saline via the right femoral vein.
In addition, Shock Index (SI) was used to assess whether
HS model was succesful or not. SI is less than 0.5, which
shows that the body is no shock. SI is greater than or
equal to 1.0, which means the body is shock.
Animals were randomly divided into 3 group (n = 24,
each): BC group (blank control group): no shock; NR
group (normal resuscitation group): HS + intravenous
resuscitation with the return of the shed blood + 2 volumes
of normal saline (NS); and DHFZTgroup: HS + intravenous
resuscitation with the return of the shed blood + 2 volumes
of NS +DHFZT. 62 mg/kg of DHFZT extract dissolved in
2 ml of 0.9% normal saline was admnistered to DHFZT,
but an equal volume of 0.9% saline was given to NR group
through jejunum fistula Prepared at before and after the
resuscitation and 3, 9 h post-resuscitation. All rats in
BC group need perform surgical operations including
intubating tube in the right carotid artery and the left
femoral artery right and the right femoral vein. Two
other groups also need to do so. The animals of NR and
DHFZT group were killed at 1, 6, 12 h post-resuscitation.
The euthanasia was realized by cervical dislocation.
Before rats killed, serum was obtained and stored at −20°C
until using for the analysis of endotoxin, IFABP. Small
intestine then were harvested for the analysis of p-VASP
and ZO-1 protein.
Measurement of serum endotoxin, IFABP
The serum concentration of endotoxin were measured
by EKT-5 M set dynamic Gram-negative bacteria test kit
through kinetic turbidimetric assay. The blood samples
for IFABP was assayed by commercially available ELISA
kits according to the manufacturer’s instructions.
Analysis of blood flow of the small intestine
To measure blood flow of the small intestine by laser
speckle perfusion imaging system.
Analysis of ZO-1 protein and p-VASP in small intestinal
tissue by western blotting and immunohistochemistry
Expression of ZO-1 and p-VASP were measured by
Western blotting. Intestinal tissue was frozen, stored
at −80°C. Protein (20 μg) was electrophoresed through
a 10-20% Tricinegradient gel (GE Healthcare Life
Sciences, Beijing), transferred tonitrocellulose membrane
(MSI, Westboro) and blocked with TBST (Tris-buffered
saline with Tween-20) containing 5% non-fat dry milk.
Protein was quantified by a protein nucleic acid analyzer
(bicinchoninic acid assay, NanoVue, GE Healthcare Life
Sciences, United States). First antibody (1:1000; SantaCruz Biotechnology) or anti-β-actin (1:2000; Santa Cruz
Biotechnology) were incubated overnightat 4°C. Membranes
were incubated with horseradish peroxidase-labeled
secondary antibody (1:3000, Santa Cruz Biotechnology) and
developed with UVP gel imaging analysis analyzer systems
(UVP Co, Ltd., United States). Blot densitometrical
analyses were performed using the Quantity One software
(Bio-Rad Laboratories, Hercules).
In addition, SP immunohistochemistry technique (IHC)
was used to evaluate those expression. The tissue sample
was fixed in neutral formalin (4%), embedded in paraffin,
stained using SP-IHC, DAB color, dried and observed
by light microscopy. Immunohistochemical score was
measured using the immunoreactive score developed
by Remmele and Stagner [15].
Histopathological observation of intestinal tissue by HE
stained
Intestinal tissue was fixed with formaldehyde solution
(10%), dehydrated with graded alcohol, embedded in
paraffin, sliced into cuts of 4 μm, and stained by
hematoxylin eosin staining (HE). Pathological changes of
intestinal tissue were observed by light microscopy.
Injury of the small intestine were assessed using the
score developed by Chiu [16].
Statistical analysis
Data are presented as the mean ± SD values. SPSS
version 17.0 was used to analyse the data. For comparison
among groups, T tests and one-way analysis of variance
(ANOVA) tests were used. P-value less than 0.05 was
considered statistically significant.
Results
Change of Mean Arterial Pressure (MAP) and Shock
Index (SI)
As expected, HS produced and fell to 40 mmHg in MAP
in all hemorrhaged rats. There was no significant difference
in the level of hypotension between the NR group and
DHFZT group. Resuscitation was not fully restored and
maintained MAP to pre-HS baseline in NR group and
DHFZT group where the shed blood was returned. In
contrast, MAP in DHFZTgroup was only slightly improved
at 6, 9, 12 h post-resuscitation compared with NR group,
but P>0.05 (Figure 1A).
To know whether HS model was succesful or not and
severity degree of HS, we assessed change of SI in all
rats. In Figure 1(B), SI during HS and post-resuscitation in
the NR group and DHFZT group was a remarkable
increase compared with BC group. After given DHFZT, SI
presented a downward trend in post-resuscitation, which
indicated that shock status of body was gradually been
improved.
Figure 1 Change of Mean Arterial Pressure (MAP) and Shock Index (SI). (A): change of MAP; (B) change of SI. BC group (blank control group) = no
shock; NR group (normal resuscitation group) = HS + intravenous resuscitation with the return of the shed blood+ 2 volumes of normal saline (NS);
DHFZT group (Dai Huang Fu Zi Tang group) = HS + intravenous resuscitation with the return of the shed blood + 2 volumes of NS + DHFZT. BL, baseline;
RES, resuscitation. Versus BC, *P<0.05, **P<0.01; Versus NR, #P<0.05, ##P<0.01.
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with HS
As illustrated in Figure 2, HS caused a marked reduction
in intestinal blood flow. In NR group, intestinal blood flow
with 60 minutes has not been improved by resuscitaion
with the return of the shed blood + 2 volumes of normal
saline (NS). Intestinal blood flow after HS has gradually
increased slowly after 1 h post-resuscitation, but much less
than BC group at post-resuscitation. Compared with NR
group, intestinal blood flow in DHFZT group increased
significantly since 60 minutes resuscitation until 12 h
post-resuscitation (P < 0.05 and P < 0.01, respectively).
Effects of DHFZT on ZO-1 and p-VASP in intestinal tissue
by western blotting and immunohistochemical staining
The expression of ZO-1 and p-VASP of intestinal
tissue were detected by western blotting at 1, 6, 12 hFigure 2 DHFZT significantly increased intestinal blood flow in rats w
(normal resuscitation group) = HS + intravenous resuscitation with the retur
(Dai Huang Fu Zi Tang group) = HS + intravenous resuscitation with the ret
resuscitation; Versus BC, *P<0.05, **P<0.01. Versus NR, #P<0.05, ##P<0.01.post-resuscition and immunohistochemical staining at
12 h post-resuscition, as illustrated in Figures 3 and 4.
The expression of ZO-1 protein in NR group was
significantly downregulated, and p-VASP upregulated
by western blotting compared with BC group at 1 h
after resuscitation (P < 0.01). After DHFZT treatment, the
expression of ZO-1 protein was upregulated, and p-VASP
downregulated at 6, 12 h post-resuscitation compared with
NR group (P < 0.05 and P < 0.01, respectively). Moreover,
immunohistochemical staining was used to illustrate the
effect of DHFZT on ZO-1 and p-VASP of intestinal tissue
at 12 h post-resuscitation. ZO-1 protein showed a strong
positive expression in BC group, and slightly negative
expression in NR group and moderate positive expression
in DHFZT group at post-resuscitation, but p-VASP was
just the opposite. In NR group, The expression of ZO-1
protein was markedly decreased (P < 0.01, vs BC group),ith HS. BC group (blank control group) = no shock; NR group
n of the shed blood + 2 volumes of normal saline (NS); DHFZT group
urn of the shed blood + 2 volumes of NS + DHFZT. BL, baseline; RES,
Figure 3 Effects of DHFZT on ZO-1 and p-VASP protein in intestinal tissue measured by western blotting. ZO-1, zonula occludens-1;
p-VASP, phosphorylated vasodilator-stimulated phosphoprotein; BC, blank control group; NR, normal resuscitation group; DHFZT, Dai Huang Fu Zi
Tang group. BL, baseline; RES, resuscitation; β-actin was used as an intrinsic control. Versus BC, aP<0.05, bP<0.01; Versus NR, cP<0.05, dP<0.01.
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BC group), which indicated that HS lead to the
minute structure damages of the intestinal tissue.
Compared with NR group, the expressions of ZO-1
protein was up-regulated at 6, 12 h post-resuscitation
(P < 0.05 and P < 0.01, respectively), but p-VASP down-
regulated by DHFZT at 1, 6, 12 h post-resuscitation
(1 h, P < 0.05; 6, 12 h, P < 0.01), indicating the minute
structure damages of the intestinal tissue were alleviated
by DHFZT after HS.
DHFZT significantly relieved pathological damage of
intestinal tissue and reduced intestinal epithelial damage
index
The results of HE staining revealed severe edema, massive
coloboma, necrosis, shedding, collapsed submucosal
vessels, and necrotic mucosal lamina propria glands
in NR group. Histologic lesion of intestinal tissue in
DHFZT group were significantly reduced at 6, 12 h
post-resuscitation compared with NR group. Intestinal
epithelial damage index was used to quantitative
histological lesions. Intestinal epithelial damage index in
NR group was markedly increased after HS compared
with BC group (P < 0.01). After treatment with DHFZT,
intestinal epithelial damage index was significantly
decreased at 12 h post-resuscitation compared with NR
group (P < 0.05), as shown in Figure 5.DHFZT significantly reduced the serum concentration of
IFABP and endotoxin
HS caused a marked elevation in the serum concentration
of IFABP and endotoxin. In NR group, the serum
concentration of IFABP and endotoxin has not been
significantly reduced by resuscitaion with the return
of the shed blood + 2 volumes of normal saline (NS)
singly at post-resuscitation. But rats in DHFZT group
showed significant decrease of endotoxin and IFABP
concentration at 30, 60 minute resuscitation (P < 0.05)
and 1, 3, 6, 9, 12 h (P < 0.01) post-resuscitation compared
with these of NR group, as illustrated in Figures 6 and 7.
Discussion
The present study is the first to investigate the effects of
DHFZT on intestinal blood blow, expression of p-VASP
and ZO-1, and intestinal endotoxaemia after HS. Our
studies demonstrate the following: (1) HS causes a marked
reduction in intestinal blood flow, and a significant
elevation in serum endotoxin, which are not improved
by normal resuscitation with shed blood + 2 volumes of NS;
(2) The expression of ZO-1 protein is significantly
downregulated, but p-VASP upregulated after HS, indicat-
ing that HS leads to the minute structure damages of
the intestinal tissue; (3) DHFZT earlier restores the
intestinal blood flow since 30 minutes resuscitaion
until 12 h post-resuscitation, but nou restores MAP.
Figure 4 Effects of DHFZT on ZO-1 and p-VASP protein in the intestinal tissue by immunohistochemical staining at 12 h post-resuscitation.
ZO-1, zonula occludens-1; p-VASP, phosphorylated vasodilator-stimulated phosphoprotein; BC, blank control group; NR, normal resuscitation group;
DHFZT, Dai Huang Fu Zi Tang group. Versus BC, aP<0.05, bP<0.01; Versus NR, cP <0.05.
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ZO-1 protein, and downregulates the expression of p-VASP
in intestinal tissue and significantly ameliorates the
pathological damage of intestinal tissue. (4) DHFZT can
distinctly decrease the serum concentration of endotoxin
and reduce the severity of intestinal endotoxaemia.
HS is induced by massive blood loss after trauma or
surgery, which leads to severe reduction in circulating
blood volume and tissue hypoperfusion. HS is characterized
by a series of physiologic compensatory adjustments
to maintain the blood-supply of vital organs like heart
and brain aimed at saving the life of the organism. At the
same time, the blood supply of the intestine is greatly
reduced, and with resuscitation, a repersusion injury
is introduced to cause obligatory fluid sequestration and
enhance intestine-derived endotoxemia and exaggerated
systemic inflammatory respose. Given this interrelatedpathophysiology, it is reasonable to suggest that intestinal
blood blow should be restored as soon as possible. A study
has shown that the shock-induced intestinal microvascular
derangemengts and endothelial cell dysfunction can
only partially be attennated with a resuscitation regimen
containing blood [17]. The present study aslo has demon-
strated that DHFZT obviously increased intestinal blood
blow and serum concentration of IFABP realesed from
broken gastrointestinal epithelial cells, which can be easily
detected when the intestinal mucosa is ischemia and
hypoxia. Serum concentration of IFABP is a marker of
damage of the intestinal mucosa [18,19]. The authors
found that when HS, IFABP quickly entered into the
blood, and then leaded to high serum IFABP, indicating
HS causes damage of the intestine [20]. But this has
not improved by shed blood and NS. It is interesting that,
as shown in this study, DHFZT shows significant decrease
Figure 5 DHFZT significantly relieved pathological damage of intestinal tissue and reduced intestinal epithelial damage index
(magnification, × 100). HE, hematoxylin-eosin staining; BC, blank control group; NR, normal resuscitation group; DHFZT, Dai Huang Fu Zi Tang
group. Versus BC, bP<0.01; Versus NR, cP <0.05.
Figure 6 DHFZT reduce the serum concentration of IFABP. IFABP, Intestinal fatty acid binding protein; BC, blank control group; NR, normal
resuscitation group; DHFZT, Dai Huang Fu Zi Tang group. Versus BC, *P<0.05, **P<0.01, and Versus NR, #P <0.05, ##P<0.01.
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Figure 7 DHFZT reduce the serum concentration of endotoxin.
BC, blank control group; NR, normal resuscitation group; DHFZT, Dai
Huang Fu Zi Tang group. Versus BC, *P<0.05, **P<0.01, and Versus
NR, #P <0.05, ##P<0.01.
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that DHFZT have a therapeutic and protective effect on
intestinal mucosal injury after HS. The protective effect is
testfied that the pathological damage of intestinal tissue in
HS is sharply reduced after administration of DHFZT.
The intercellular junction of the intestinal epithelial
cells is responsible for maintaining intestinal mechanical
barrier [21,22]. Tight junction is regarded as the most
important foundation for maintaining the structure of
intestinal mucosal mechanical barrier. ZO-1 protein is
one of tight joint structural proteins that found in the
surface of the cytoplasmic membrane [23]. Its main
function is to maintain and regulate the barrier function,
which also involves regulation of cell proliferation and
differentiation, maintaining epithelial polarity, transporting
cell material. VASP, as a protein involved in skeletal cells,
belongs to a family of Ena/VASP proteins [24,25]. It
is located in the intercellular junction, focal adhesion of
stress fiber terminal and is a highly dynamic change area
on the cellular membrane. VASP has three phosphorylation
sites, two of which are for serine loci (Serl57, Ser239) and
the other is for THR loci (Thr278). In normal intestinal
epithelial cells (IEC), VASP and ZO-1 are both located
in the intercellular junction. VASP in the aspects of
expression, distribution density is closely associated with
ZO-l protein [26]. Recovery of tight junction and
barrier function depend on VASP phosphorylation.
VASP can mediate morphological change of ZO-1 by
phosphorylating Serl57, which regulates tight junction
and cell barrier function. In this study, the expression
of p-VASP in the NR group was significantly increased
compared with the BC group, but markedly decreased
and significantly increased in the DHFZT group, which
indicated DHFZT can protect intercellular junction of
the intestinal epithelial cells, and then maintain normalintestinal mechanical barrier by regulating the expression
of ZO-1 protein and VASP phosphorylation. Luyer et al.
found that the tight junction protein ZO - l was lost and
p-VASP increased under low intestinal blood flow in
shock rats, at the same time, permeability of the intestinal
mucosa and bacteria translocation have also increased
[27]. The study aslo has showed the more expressions of
ZO-1, the more intestinal blood flow in NR group and
DHFZT group. But the relationship between p-VASP and
intestinal blood flow was just the opposite.
The injury of intestinal mucosa barrier caused by
intestinal ischemia could increase permeability of intestinal
mucosa for endotoxin, which afterwards give rise to
endoxemia and serious consequences such as the systemic
inflammatory response syndrome (SIRS), the multiple
organ dysfunction syndrome (MODS) etc. Few studies
have shown that the prognosis of HS closely relates to the
enterogenous endotoxemia, which cannot be reverted
by intravenous fluid resuscitation [28,29]. Therefore,
reducing the concentration of the enterogenous endotoxin
will help to improve the prognosis of HS. The results of
our study indicated that the level of serum endotoxin
remarkablely elevated since 60 minutes after HS, which
indicate that HS gave rise to intestinal dysbacteriosis and
the overgrowth of Gram-negative bacteria, then a large
amounts of endotoxin permeated the damaged intestinal
mucosal barrier and entered the bloodstream.
Conclusions
The results of our study indicate that DHFZT siginificantly
improves intestinal blood flow, protects the intestinal
barrier function by up-regulating the expression of ZO-1
protein and down-regulating expression of p-VASP,
and finally ameliorates intestinal endotoxaemia after
HS. But DHFZT can not markedly improve the reduction
of mean arterial pressure in HS. In short, these results
suggest that DHFZT may be a useful herbal formula
for restoring ingtestinal blood flow, protecting intestinal
mechanical barrier and reducing the degree of enterogenous
endotoxemia when the HS.
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